Table 2.
Relation between IFITM2 expression and clinical characteristics
| Characteristics | Total(N) | Odds Ratio(OR) | P value |
|---|---|---|---|
| Age (< = 65 vs. > 65) | 644 | 1.135 (0.831–1.552) | 0.426 |
| Gender (Female vs. Male) | 644 | 0.940 (0.689–1.281) | 0.693 |
| T stage (T1 vs. &T2T3&T4) | 641 | 1.231 (0.838–1.812) | 0.291 |
| N stage (N0 vs. N1&N2) | 640 | 1.396 (1.019–1.913) | 0.038 |
| M stage (M0 vs. M1) | 564 | 1.652 (1.107–2.477) | 0.014 |
| Pathologic stage (Stage I vs. Stage II& Stage III&Stage IV) | 623 | 1.413 (1.029–1.942) | 0.033 |